Schedule 13G ownership disclosure

DRUGS MADE IN AMER ACQUTN CO

Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G2847J104

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • First Trust Merger Arbitrage Fund

    Shares: 1,781,724.00 · Class: 5.32%

  • First Trust Capital Management L.P.

    Shares: 2,066,702.00 · Class: 6.17%

  • First Trust Capital Solutions L.P.

    Shares: 2,066,702.00 · Class: 6.17%

  • FTCS Sub GP LLC

    Shares: 2,066,702.00 · Class: 6.17%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001604488-25-000134
Form type
SCHEDULE 13G
Filer
Drugs Made In America Acquisition Corp.
CIK
CIK 2028614
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub